Flora Growth Corp. Announces Transition of Hussein Rakine from Director to Special Advisor

Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary
Flora Growth Corp. announces resignation of Director Hussein Rakine, who will continue as a Special Advisor. The company expects to launch a medical cannabis line in Germany. Rakine will provide strategic counsel for new product launches.
  • None.
  • None.

Fort Lauderdale, Florida--(Newsfile Corp. - October 2, 2023) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company"), a global consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution, has announced that Hussein Rakine resigned from his role as Director, but will continue as serve as a Special Advisor to the Company.

"I would like to thank Mr. Rakine for his contributions to Flora. Mr. Rakine is a serial entrepreneur and the founder of Just Brands LLC ("JUST") - the backbone of our business in the United States. As our operations mature, it is natural for the founder to transition and I am pleased that Mr. Rakine will continue to serve as a Special Advisor to the Company," commented Clifford Starke, Chief Executive Officer.

In addition to JUST's and Vessel's existing product portfolio based in Europe, the Company expects to launch JUSTthc - a medical cannabis line - in Germany. Mr. Rakine will provide strategic counsel and work closely with Flora's executive team to identify opportunities for new product launches and development.

About Flora Growth Corp.

Flora Growth Corp. is a global consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution. For more information on Flora, visit

Cannot view this image? Visit:

To view an enhanced version of this graphic, please visit:

Investor Relations:

Investor Relations
Clifford Starke


Cautionary Statement Concerning Forward Looking Statements

This press release contains "forward looking statements," as defined by federal securities laws. Forward-looking statements reflect Flora's current expectations and projections about future events at the time, and thus involve uncertainty and risk. The words "believe," "expect," "anticipate," "will," "could," "would," "should," "may," "plan," "estimate," "intend," "predict," "potential," "continue," and the negatives of these words and other similar expressions generally identify forward looking statements. Such forward looking statements are subject to various and risks and uncertainties, including those described under section entitled "Risk Factors" in Flora's Annual Report on Form 10K filed with the SEC on March 31, 2023, as such factors may be updated from time to time in Flora's periodic filings with the SEC, which are accessible on the SEC's website at Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in Flora's filings with the SEC. While forward looking statements reflect Flora's good faith beliefs, they are not guarantees of future performance. Flora disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this press release, except as required by applicable law. You should not place undue reliance on any forward-looking statements, which are based on information currently available to Flora (or to third parties making the forward-looking statements).

To view the source version of this press release, please visit

Flora Growth Corp.


FLGC Rankings

FLGC Latest News

FLGC Stock Data

All Other Miscellaneous Chemical Product and Preparation Manufacturing
United States of America

About FLGC

at flora growth corp. (flora), we are building the world’s largest and lowest cost vertically-integrated producer of organic cannabis and pharmaceutical-grade medical products as well as cbd-based consumer products.